Dapagliflozin and Metformin Hydrochloride Extended-release Tablet
Type 2 Diabetes (Metabolism)
ApprovedCommercial (China)
Key Facts
About Sinotherapeutics
A Chinese pharma company developing complex generics and novel formulations with FDA/NMPA-approved products in oncology, immunology, and metabolic diseases.
View full company profile